Correction: YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma

PDF  |  How to cite

Oncotarget. 2023; 14:280-280. https://doi.org/10.18632/oncotarget.28393

Metrics: PDF 404 views  |   ?  

Tao Guo1,2,*, Shilei Zhao1,2,*, Peng Wang1,2,*, Xiaoyuan Xue3, Yan Zhang4, Mengying Yang3, Nan Li3, Zhuoshi Li1,2, Lingzhi Xu5, Lei Jiang6, Lei Zhao1,2, Patrick C. Ma7, Rafael Rosell8, Jinxiu Li2 and Chundong Gu1,2

1Department of Thoracic Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China
2Lung Cancer Diagnosis and Treatment Center of Dalian, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China
3Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China
4Department of Radiation Oncology, Qianfoshan Hospital Affiliated to Shandong University, Jinan 250000, China
5The Second Affiliated Hospital, Dalian Medical University, Dalian 116011, China
6The Fourth Affiliated Hospital, Anhui Medical University, Hefei 230000, China
7Aerodigestive Oncology Translational Research THOR, Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44195, USA
8Breakthrough Cancer Research Unit, Pangaea Biotech, Dexeus University Institute, Catalan Institute of Oncology, Badalona 08916, Spain
Written on behalf of the AME Thoracic Surgery Collaborative Group
*These authors have contributed equally to this work

Published: March 31, 2023

Copyright: © 2023 Guo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been corrected: In Figure 2D, the ‘shYB1-3’ panel contains an accidental overlap of the ‘shYB1-3’ panel in Figure 3B. The corrected Figure 2D, produced using the original data, is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original article: Oncotarget. 2017; 8:48110–48125. DOI: https://doi.org/10.18632/oncotarget.18262

Figure 2: Inhibition of YB-1suppresses migration of lung adenocarcinoma cells. (A, B) Wound healing assay of lung adenocarcinoma cells in the YB-1-silenced cells (shYB1-1 and shYB1-2: YB-1-silenced A549 cells; shYB1-3 and shYB1-4: YB-1-silenced H1299 cells) and their corresponding control cells. The distance from the wound edge was calculated with corresponding summary (right panel). (C, D) Transwell assay in lung adenocarcinoma cells in the YB-1-silenced cells and their corresponding control cells. Columns were averaged from three independent experiments. *P < 0.05, ***P < 0.01, ***P < 0.005, two-tailed Student’s T-tests. Error bars represent mean ± s.d. Scale bars, 100 μm (A, B), 50 μm (C, D).

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28393